1. The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis
    Ilary Ruscito et al, 2021, Cancers CrossRef
  2. A pilot study on DNA hypermethylation status in promoter region of P16 gene in patients with sporadic breast cancer
    Kapil Bhatia et al, 2022, Medical Journal Armed Forces India CrossRef
  3. Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer
    Olga Lobanova et al, 2022, Breast Cancer Research and Treatment CrossRef
  4. BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine
    Maria Panagopoulou et al, 2024, Clinical Epigenetics CrossRef
  5. Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer
    Farman Ullah et al, 2015, PLOS ONE CrossRef

  6. Regulation of RUNX3 Expression by DNA Methylation in Prostate Cancer


    Xin Yang et al, 2020, Cancer Management and Research CrossRef
  7. Insights into the Cellular Uptake, Cytotoxicity, and Cellular Death Modality of Phospholipid-Coated Gold Nanorods toward Breast Cancer Cell Lines
    Nouf N. Mahmoud et al, 2019, Molecular Pharmaceutics CrossRef
  8. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study
    Catherine L. Callahan et al, 2016, Epigenetics CrossRef
  9. Global DNA methylation profile at LINE-1 repeats and promoter methylation of genes involved in DNA damage response and repair pathways in human peripheral blood mononuclear cells in response to γ-radiation
    Rashmi Priya et al, 2022, Molecular and Cellular Biochemistry CrossRef
  10. CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT
    Л. Фіщук et al, 2023, Experimental Oncology CrossRef
  11. Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women
    Nisreen Al-Moghrabi et al, 2024, International Journal of Molecular Sciences CrossRef
  12. Methylation of BRCA1 promoter in sporadic breast cancer
    SunilVitthalrao Jagtap et al, 2023, Indian Journal of Medical Research CrossRef
  13. Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF)
    Sreelatha K. Hemalatha et al, 2018, Scientific Reports CrossRef
  14. SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer
    Lei Zhang et al, 2021, Anti-Cancer Drugs CrossRef
  15. Epigenetic modulation of BRCA‐1 and MGMT genes, and histones H4 and H3 are associated with breast tumors
    Parisa Paydar et al, 2019, Journal of Cellular Biochemistry CrossRef
  16. Dysregulation of ubiquitin ligases in cancer
    Jianfei Qi et al, 2015, Drug Resistance Updates CrossRef
  17. Emerging patterns and implications of breast cancer epigenetics
    Thejaswini Venkatesh et al, 2021, Epigenetics and Reproductive Health CrossRef
  18. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer
    Sumin Oh et al, 2017, Translational Research in Breast Cancer CrossRef